DK319381A - Fremgangsmaade til fremstilling af ferrihydroxid-dextran-komplekser - Google Patents

Fremgangsmaade til fremstilling af ferrihydroxid-dextran-komplekser

Info

Publication number
DK319381A
DK319381A DK319381A DK319381A DK319381A DK 319381 A DK319381 A DK 319381A DK 319381 A DK319381 A DK 319381A DK 319381 A DK319381 A DK 319381A DK 319381 A DK319381 A DK 319381A
Authority
DK
Denmark
Prior art keywords
dextran
solution
added
iron
vals
Prior art date
Application number
DK319381A
Other languages
English (en)
Other versions
DK171847B1 (da
Inventor
W Richle
A Mueller
Original Assignee
Hausmann Ag Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hausmann Ag Labor filed Critical Hausmann Ag Labor
Publication of DK319381A publication Critical patent/DK319381A/da
Application granted granted Critical
Publication of DK171847B1 publication Critical patent/DK171847B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK319381A 1980-07-16 1981-07-16 Fremgangsmåde til fremstilling af ferri-hydroxid-dextran-komplekser DK171847B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3026868 1980-07-16
DE3026868A DE3026868C2 (de) 1980-07-16 1980-07-16 Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung

Publications (2)

Publication Number Publication Date
DK319381A true DK319381A (da) 1982-01-17
DK171847B1 DK171847B1 (da) 1997-06-30

Family

ID=6107296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK319381A DK171847B1 (da) 1980-07-16 1981-07-16 Fremgangsmåde til fremstilling af ferri-hydroxid-dextran-komplekser

Country Status (7)

Country Link
US (1) US4599405A (da)
EP (1) EP0044050B1 (da)
JP (1) JPS5742701A (da)
AT (1) ATE11784T1 (da)
DE (1) DE3026868C2 (da)
DK (1) DK171847B1 (da)
YU (1) YU43027B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187167B (en) * 1982-10-15 1985-11-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical solution of new type polynuclear iron/iii/ mixed complex activity
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
US5314679A (en) * 1986-07-03 1994-05-24 Advanced Magnetics Inc. Vascular magnetic resonance imaging agent comprising nanoparticles
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
WO1992022586A1 (fr) * 1991-06-11 1992-12-23 Meito Sangyo Kabushiki Kaisha Composite oxyde comprenant du carboxypolysaccharide hydrosoluble et de l'oxyde de fer magnetique
DE4239442C2 (de) * 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US5624668A (en) * 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
US5756715A (en) * 1996-11-08 1998-05-26 Abbott Laboratories Process for making crystalline iron dextran
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
WO2007081744A2 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
PT2319804E (pt) * 2006-12-14 2014-11-24 Novartis Ag Adsorvente de fosfato à base de ferro (iii)-carboidrato
EP1947120A1 (de) * 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
DE102007054794A1 (de) * 2007-11-13 2009-05-14 Agilan Gmbh Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen
BRPI0924653B8 (pt) 2009-03-25 2021-05-25 Pharmacosmos Holding As composto de ferro-oligossacarídeo, composição e uso de deste composto
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB748024A (en) * 1953-02-27 1956-04-18 Benger S Ltd Improved therapeutic preparations of iron
DE1172250B (de) * 1958-02-13 1964-06-18 Hausmann Ag Labor Verfahren zur Herstellung von therapeutisch verwendbaren Eisen(ó¾)-Dextran-Komplex-verbindungen
DE1196629B (de) * 1961-11-30 1965-07-15 Hausmann Ag Labor Verfahren zur Herstellung von nichtionischen, therapeutisch verwertbaren Ferrihydroxyd-Dextran-Komplexen
CH370194A (de) * 1961-12-06 1963-06-30 Hausmann Ag Labor Verfahren zur Herstellung von therapeutisch verwendbaren Eisenpräparaten
DK122890B (da) * 1964-12-29 1972-04-24 J Reumert Fremgangsmåde til fremstilling af ferrihydroxiddextrankomplekser.
GB1200902A (en) * 1967-05-13 1970-08-05 Fisons Pharmaceuticals Ltd Iron-dextran complexes
DE1954960A1 (de) * 1968-11-01 1970-05-14 Christensen Dr Med Henry Marin Verfahren zur Herstellung von Eisen-Dextran-Praeparaten
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
JPS5112918A (ja) * 1974-07-22 1976-01-31 Meito Sangyo Kk Dekisutoranntetsusakutaino seiho
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same

Also Published As

Publication number Publication date
YU43027B (en) 1989-02-28
DK171847B1 (da) 1997-06-30
DE3026868C2 (de) 1986-03-13
ATE11784T1 (de) 1985-02-15
YU176481A (en) 1984-02-29
DE3026868A1 (de) 1982-01-28
EP0044050B1 (de) 1985-02-13
EP0044050A2 (de) 1982-01-20
JPS5742701A (en) 1982-03-10
US4599405A (en) 1986-07-08
JPH023401B2 (da) 1990-01-23
EP0044050A3 (en) 1982-04-28

Similar Documents

Publication Publication Date Title
EP0044050A3 (en) Process for preparing ferrihydroxide-dextran complexes, and a pharmaceutical sterile solution containing them
JPS4994805A (da)
ATE81585T1 (de) Herstellung von antiperspiranten.
ES8102063A1 (es) Procedimiento para separar arsenico de un medio acuoso que lo contiene
ES8105421A1 (es) Procedimiento para tratar generos textiles usados mejorando su aspecto
PT86400A (en) Process for preparing aqueous solutions containing a mixture of hysozyme hydrochloride and dipotassium glycyrrhizate
ATE21251T1 (de) Verfahren zur herstellung von celluloseethern mit verbessertem dispergierverhalten.
JPS56500964A (da)
ES8307019A1 (es) Procedimiento para la obtencion de curtientes hidrosolubles o autodispersantes.
DE3261311D1 (en) Pretreatment composition for phosphatising ferrous metals, and method of preparing the same
ES8306994A1 (es) Procedimiento para la obtencion de diamidas de acido hidroxi-maloico sustituidas.
ZA806122B (en) Preparation of erythro- -piperid-2-yl-2,8-bis-(trifluoromethylquinolin-4-yl-methanol
DE3162131D1 (en) Process for the preparation of phospho-hydroxy-acetonitrile
AU4821279A (en) Aqueous dispersions of polymers
GB1334834A (en) Production of aminomethylene phosphonic acids
ES483909A1 (es) Procedimiento para la produccion de resinas melamino-fenol- aldehidicas fundamentalmente blancas y resistentes al amari-lleo
GB803179A (en) Process for the preparation of hypophosphites
ES449103A1 (es) Procedimiento para la preparacion de soluciones de fosfato de metales alcalinos con bajos contenidos de vanadio.
ATE134984T1 (de) Verfahren zur herstellung einer alkali- und/oder erdalkalihaltigen aluminiumtriformiatlösung, hochkonzentrierte alkali- und/oder erdalkalihaltige aluminiumtriformiatlösungen und ihre verwendung
DK0646042T3 (da) Fremgangsmåde til elektrokemisk fremstilling af dicarboxylsyrer
GB1388936A (en) Chloroisocyanuric acids
DE3068259D1 (en) Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production
GB1394845A (en) Process for the preparation of penicillamine
GB816236A (en) Improvements in the preparation of phenanthridine compounds
KR860004054A (ko) 1-(2-테트라히드로푸릴)-5-플루오로우라실의 제조방법

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed